Figure 2.
(A–D) Change in response to pp65 and IE1 antigens from baseline to week 2 and from baseline to week 4 in patients with and without a CS-CMVi. Box, IQR; vertical lines, minimum and maximum; diamond, mean; horizontal line, median. CS-CMVi, clinically significant CMV infection; IE1, immediate early 1; pp65, phosphoprotein 65.

(A–D) Change in response to pp65 and IE1 antigens from baseline to week 2 and from baseline to week 4 in patients with and without a CS-CMVi. Box, IQR; vertical lines, minimum and maximum; diamond, mean; horizontal line, median. CS-CMVi, clinically significant CMV infection; IE1, immediate early 1; pp65, phosphoprotein 65.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close